ANGPTL4 and osteosarcoma: As hypoxia and HIF correlate with the progression and recurrence of osteosarcoma and are predictive of poor survival [2–8], increased expression of ANGPTL4 in stage 2 pre-metastatic disease is potentially a mediator of this phenotype.